Clinical outcomes of 130 patients with primary and secondary lung tumors treated with Cyberknife robotic stereotactic body radiotherapy
By:
Authors
Zsolt Levente Janvary
Division of Radiotherapy, Department of Clinical Oncology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
Nicolas Jansen
Department of Radiation Oncology, Liege University Hospital, Liege, Belgium
Veronique Baart
Department of Radiation Oncology, Liege University Hospital, Liege, Belgium
Magali Devillers
Department of Radiation Oncology, Liege University Hospital, Liege, Belgium
David Dechambre
Department of Radiation Oncology, Liege University Hospital, Liege, Belgium
Eric Lenaerts
Department of Radiation Oncology, Liege University Hospital, Liege, Belgium
Laurence Seidel
Department of Biostatistics, Liege University Hospital, Liege, Belgium
Nicole Barthelemy
Department of Radiation Oncology, Liege University Hospital, Liege, Belgium
Patrick Berkovic
Department of Radiation Oncology, Liege University Hospital, Liege, Belgium
Akos Gulyban
Department of Radiation Oncology, Liege University Hospital, Liege, Belgium
Ferenc Lakosi
Department of Radiation Oncology, Liege University Hospital, Liege, Belgium
Zsolt Horvath
Division of Radiotherapy, Department of Clinical Oncology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
Philippe A. Coucke
Department of Radiation Oncology, Liege University Hospital, Liege, Belgium
Language: English
Page range: 178 - 186
Submitted on: Dec 15, 2016
Accepted on: Feb 27, 2017
Published on: Apr 3, 2017
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2017 Zsolt Levente Janvary, Nicolas Jansen, Veronique Baart, Magali Devillers, David Dechambre, Eric Lenaerts, Laurence Seidel, Nicole Barthelemy, Patrick Berkovic, Akos Gulyban, Ferenc Lakosi, Zsolt Horvath, Philippe A. Coucke, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.